BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

CSS LLC/IL's Holding History (CIK: 0001103646)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 26,500,000 Value ($000) $29,829 Avg Close — Range —
Q3 2025
Shares 1,500,000 Value ($000) $1,485 Avg Close — Range —
Q2 2025
Shares 6,238,000 Value ($000) $5,848 Avg Close — Range —
Q1 2025
Shares 4,500,000 Value ($000) $4,046 Avg Close — Range —
Q4 2024
Shares 10,000,000 Value ($000) $8,540 Avg Close — Range —
Q3 2024
Shares 1,743,000 Value ($000) $1,459 Avg Close — Range —
Q2 2024
Shares 1,043,000 Value ($000) $843 Avg Close — Range —
Q1 2024
Shares 1,043,000 Value ($000) $859 Avg Close — Range —
Q4 2023
Shares 5,043,000 Value ($000) $4,260 Avg Close — Range —
Q3 2023
Shares 5,000,000 Value ($000) $3,725 Avg Close — Range —